Valuation check: BRSF's profit margin is -5350.94%, below the sector sector average of 13.4%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2022
Trailing 12 months ending Dec 2022
The latest profit margin for BRSF is -5350.94% as of December 2022. That compares with -3424.57% in the prior-year period — down 56.3% year over year. That is below the sector sector average of 13.4%. Investors often review this figure alongside Brain Scientific's historical trend and sector peers before judging valuation or financial health.
Over the past year, BRSF's profit margin moved from -3424.57% to -5350.94% — a 56.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Brain Scientific's valuation or profitability profile.
Against its sector companies, BRSF currently prints -5350.94% for profit margin, while the sector average sits near 13.4%. That is roughly 40022.1% below the sector mean. Large gaps often invite a closer look at Brain Scientific's growth, margins, and balance sheet.
Profit Margin shows how effectively Brain Scientific converts resources into returns. At -5350.94%, BRSF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3424.57% in the prior-year period — down 56.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting BRSF's profit margin (-5350.94%), review year-over-year change from -3424.57%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.